![Friedrich Hillebrand](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Friedrich Hillebrand is currently the Director at UroMems SAS and Co-Managing Director at EVER Pharma Holding GmbH.
Previously, he worked as the Chief Executive Officer at EBEWE Pharma Ges.m.b.
H.
Nfg.KG and Co-Managing Director at EVER Neuro Pharma GmbH.
Postes actifs de Friedrich Hillebrand
Sociétés | Poste | Début |
---|---|---|
EVER Pharma Holding GmbH
![]() EVER Pharma Holding GmbH Pharmaceuticals: MajorHealth Technology EVER Pharma Holding GmbH engages in the research in as well as development, production, and distribution of pharmaceutical products in the areas of neurology, intensive medicine, anesthesiology, and oncology. Its business activities also include the management and strategic development of shareholdings. The company was founded on August 25, 2001 and is headquartered in Salzburg, Austria. | Directeur Général | - |
UroMems SAS
![]() UroMems SAS Medical SpecialtiesHealth Technology UroMems SASdesigns and develops implantable medical devices. Its product is an active implantable medical device which compensates for sphincter insufficiency with the help of a MyoElectroMechanical System. The company was founded by Hamid Lamraoui in 2011 and is headquartered in Grenoble, France. | Directeur/Membre du Conseil | - |
Anciens postes connus de Friedrich Hillebrand
Sociétés | Poste | Fin |
---|---|---|
EVER Neuro Pharma GmbH
![]() EVER Neuro Pharma GmbH Pharmaceuticals: MajorHealth Technology Part of EVER Pharma Holding GmbH, EVER Neuro Pharma GmbH is an Austrian company that engages in research, development, production and commercialization of pharmaceutical products. The company is based in Unterach, Austria. The company was founded in 1934. The CEO is Georges Kahwati. | Directeur Général | - |
EBEWE Pharma Ges.m.b.H. Nfg.KG
![]() EBEWE Pharma Ges.m.b.H. Nfg.KG Pharmaceuticals: MajorHealth Technology EBEWE Pharma Ges.m.b.H. Nfg.KG engages in the development and manufacture of injectable pharmaceutical specialties. The firm offers therapy solutions for colon, lung, breast, and prostate cancer. It also specializes in drug and pharmaceutical development, as well as preclinical studies. The company was founded in 1934 and is headquartered in Unterach am Attersee, Austria. | Directeur Général | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 4 |
---|---|
EBEWE Pharma Ges.m.b.H. Nfg.KG
![]() EBEWE Pharma Ges.m.b.H. Nfg.KG Pharmaceuticals: MajorHealth Technology EBEWE Pharma Ges.m.b.H. Nfg.KG engages in the development and manufacture of injectable pharmaceutical specialties. The firm offers therapy solutions for colon, lung, breast, and prostate cancer. It also specializes in drug and pharmaceutical development, as well as preclinical studies. The company was founded in 1934 and is headquartered in Unterach am Attersee, Austria. | Health Technology |
EVER Pharma Holding GmbH
![]() EVER Pharma Holding GmbH Pharmaceuticals: MajorHealth Technology EVER Pharma Holding GmbH engages in the research in as well as development, production, and distribution of pharmaceutical products in the areas of neurology, intensive medicine, anesthesiology, and oncology. Its business activities also include the management and strategic development of shareholdings. The company was founded on August 25, 2001 and is headquartered in Salzburg, Austria. | Health Technology |
EVER Neuro Pharma GmbH
![]() EVER Neuro Pharma GmbH Pharmaceuticals: MajorHealth Technology Part of EVER Pharma Holding GmbH, EVER Neuro Pharma GmbH is an Austrian company that engages in research, development, production and commercialization of pharmaceutical products. The company is based in Unterach, Austria. The company was founded in 1934. The CEO is Georges Kahwati. | Health Technology |
UroMems SAS
![]() UroMems SAS Medical SpecialtiesHealth Technology UroMems SASdesigns and develops implantable medical devices. Its product is an active implantable medical device which compensates for sphincter insufficiency with the help of a MyoElectroMechanical System. The company was founded by Hamid Lamraoui in 2011 and is headquartered in Grenoble, France. | Health Technology |